Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process

201851 citationsJournal Articlediamond Open Access

Authors

Dorothée Faille · Sorbonne Paris Cité

Marie‐Charlotte Bourrienne · Assistance Publique – Hôpitaux de Paris

Emmanuelle de Raucourt · Université Paris Cité

Luc de Chaisemartin · Institut Galien Paris-Saclay

Vanessa Granger · Inflammation, Microbiome and Immunosurveillance

Romaric Lacroix · Aix-Marseille Université

Laurence Panicot‐Dubois

Abstract

VTE biomarkers including D-dimers and MV-TF activity are not related to inflammation but rather to cancer process and dissemination. D-dimers and MV-TF activity are associated to future VTE in PDAC patients and could help identify patients who could benefit from thromboprophylaxis.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Inflammatory Biomarkers in Disease Prognosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Oncotarget

Volume 9, Issue 41, pp. 26453-26465

DOI: 10.18632/oncotarget.25458

Field-Weighted Citation Impact: 4.70

Command Palette